Disorders of sex development: new genes, new concepts
暂无分享,去创建一个
[1] P. Canto,et al. Mutations in the desert hedgehog (DHH) gene in patients with 46,XY complete pure gonadal dysgenesis. , 2004, The Journal of clinical endocrinology and metabolism.
[2] H. Ostrer,et al. Loss of Mitogen-Activated Protein Kinase Kinase Kinase 4 (MAP3K4) Reveals a Requirement for MAPK Signalling in Mouse Sex Determination , 2009, PLoS biology.
[3] D. Geschwind,et al. Human ARX gene: genomic characterization and expression. , 2002, Molecular genetics and metabolism.
[4] V. Harley,et al. Sex determination: a ‘window’ of DAX1 activity , 2004, Trends in Endocrinology & Metabolism.
[5] W. Miller,et al. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. , 2011, Endocrine reviews.
[6] K. Tomizuka,et al. R-spondin1 plays an essential role in ovarian development through positively regulating Wnt-4 signaling. , 2008, Human molecular genetics.
[7] J. Forwood,et al. Defective importin β recognition and nuclear import of the sex-determining factor SRY are associated with XY sex-reversing mutations , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[8] G. Camerino,et al. CXorf6 is a causative gene for hypospadias , 2006, Nature Genetics.
[9] J. Bard,et al. The candidate Wilms' tumour gene is involved in genitourinary development , 1990, Nature.
[10] Michiko Nakamura,et al. Mamld1 deficiency significantly reduces mRNA expression levels of multiple genes expressed in mouse fetal Leydig cells but permits normal genital and reproductive development. , 2012, Endocrinology.
[11] R. Lovell-Badge,et al. Expression of a candidate sex-determining gene during mouse testis differentiation , 1990, Nature.
[12] G. Camerino,et al. Activation of beta-catenin signaling by Rspo1 controls differentiation of the mammalian ovary. , 2008, Human molecular genetics.
[13] L. Looijenga,et al. A 46,XY Female DSD Patient with Bilateral Gonadoblastoma, a Novel SRY Missense Mutation Combined with a WT1 KTS Splice-Site Mutation , 2012, PloS one.
[14] Y. Gondo,et al. ENU-induced mutant mice for a next-generation gene-targeting system. , 2009, Progress in brain research.
[15] K. Parker,et al. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation , 1994, Cell.
[16] Leslie G. Biesecker,et al. Opportunities and challenges for the integration of massively parallel genomic sequencing into clinical practice: lessons from the ClinSeq project , 2012, Genetics in Medicine.
[17] P. Canto,et al. A heterozygous mutation in the desert hedgehog gene in patients with mixed gonadal dysgenesis. , 2005, Molecular human reproduction.
[18] K. H. Albrecht,et al. Gonadal differentiation, sex determination and normal Sry expression in mice require direct interaction between transcription partners GATA4 and FOG2. , 2002, Development.
[19] R. Sinnott,et al. The European Disorder of Sex Development Registry: A Virtual Research Environment , 2010, Sexual Development.
[20] M. Pembrey,et al. A clinical and genetic study of campomelic dysplasia. , 1995, Journal of medical genetics.
[21] D. Wilhelm,et al. Sex determination and gonadal development in mammals. , 2007, Physiological reviews.
[22] C. S. Raymond,et al. Dmrt1, a gene related to worm and fly sexual regulators, is required for mammalian testis differentiation. , 2000, Genes & development.
[23] Marc Fellous,et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome , 1997, Nature Genetics.
[24] R. Lovell-Badge,et al. Failure of SOX9 Regulation in 46XY Disorders of Sex Development with SRY, SOX9 and SF1 Mutations , 2011, PloS one.
[25] D. Housman,et al. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour , 1991, Nature.
[26] P. Koopman,et al. Spatially dynamic expression of Sry in mouse genital ridges , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.
[27] John C. Achermann,et al. Steroidogenic factor-1 (SF-1, NR5A1) and human disease , 2011, Molecular and Cellular Endocrinology.
[28] David Housman,et al. WT-1 is required for early kidney development , 1993, Cell.
[29] ENU mutagenesis in mice identifies candidate genes for hypogonadism , 2012, Mammalian Genome.
[30] L. Gillam,et al. Ethical Principles for the Management of Infants with Disorders of Sex Development , 2010, Hormone Research in Paediatrics.
[31] B. Anderlid,et al. Characterization of deletions at 9p affecting the candidate regions for sex reversal and deletion 9p syndrome by MLPA , 2009, European Journal of Human Genetics.
[32] D. Housman,et al. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor , 1990, Cell.
[33] H. Ostrer,et al. Minor Abnormalities of Testis Development in Mice Lacking the Gene Encoding the MAPK Signalling Component, MAP3K1 , 2011, PloS one.
[34] M. Dubois‐Dauphin,et al. Gene expression during sex determination reveals a robust female genetic program at the onset of ovarian development. , 2005, Developmental biology.
[35] R. Lovell-Badge,et al. Excess DAX1 leads to XY ovotesticular disorder of sex development (DSD) in mice by inhibiting steroidogenic factor-1 (SF1) activation of the testis enhancer of SRY-box-9 (Sox9). , 2012, Endocrinology.
[36] U. Thyen,et al. Ethical principles and recommendations for the medical management of differences of sex development (DSD)/intersex in children and adolescents , 2009, European Journal of Pediatrics.
[37] K. Worley,et al. A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal , 1994, Nature Genetics.
[38] R. Lovell-Badge,et al. Sex determination and SRY: down to a wink and a nudge? , 2009, Trends in genetics : TIG.
[39] T. Ogata,et al. MAMLD1 (mastermind-like domain containing 1) homozygous gain-of-function missense mutation causing 46,XX disorder of sex development in a virilized female. , 2011, Advances in experimental medicine and biology.
[40] W. Fischer,et al. FoxL2 and Smad3 Coordinately Regulate Follistatin Gene Transcription* , 2009, Journal of Biological Chemistry.
[41] A. Munnich,et al. Disruption of a long distance regulatory region upstream of SOX9 in isolated disorders of sex development , 2011, Journal of Medical Genetics.
[42] D. Schlessinger,et al. FOXL2 and BMP2 act cooperatively to regulate follistatin gene expression during ovarian development. , 2011, Endocrinology.
[43] L. Russell,et al. Desert hedgehog (Dhh) Gene Is Required in the Mouse Testis for Formation of Adult-Type Leydig Cells and Normal Development of Peritubular Cells and Seminiferous Tubules , 2000, Biology of reproduction.
[44] N. Tommerup,et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9 , 1994, Cell.
[45] R. Lovell-Badge,et al. Fgf9 and Wnt4 Act as Antagonistic Signals to Regulate Mammalian Sex Determination , 2006, PLoS biology.
[46] E. Vilain,et al. Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/β-catenin synergy , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[47] J. W. Foster,et al. An SRY-related sequence on the marsupial X chromosome: implications for the evolution of the mammalian testis-determining gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[48] H. Mandel,et al. SERKAL syndrome: an autosomal-recessive disorder caused by a loss-of-function mutation in WNT4. , 2008, American journal of human genetics.
[49] P. Goodfellow,et al. Sox9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birds , 1996, Nature Genetics.
[50] R. Williams,et al. Williams Textbook of endocrinology , 1985 .
[51] Y. Urade,et al. The PGD2 pathway, independently of FGF9, amplifies SOX9 activity in Sertoli cells during male sexual differentiation , 2009, Development.
[52] A. Sinclair,et al. Defective survival of proliferating Sertoli cells and androgen receptor function in a mouse model of the ATR-X syndrome. , 2011, Human molecular genetics.
[53] H. Yao,et al. Sex-specific roles of beta-catenin in mouse gonadal development. , 2008, Human molecular genetics.
[54] B. Capel,et al. Balancing the bipotential gonad between alternative organ fates: A new perspective on an old problem , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.
[55] S. Ahmed,et al. Consensus Statement on Management of Intersex Disorders , 2006, Pediatrics.
[56] V. Harley,et al. The molecular action and regulation of the testis-determining factors, SRY (sex-determining region on the Y chromosome) and SOX9 [SRY-related high-mobility group (HMG) box 9]. , 2003, Endocrine reviews.
[57] D. Gerrelli,et al. Human RSPO1/R-spondin1 Is Expressed during Early Ovary Development and Augments β-Catenin Signaling , 2011, PloS one.
[58] A. Quittner,et al. Children with disorders of sex development: A qualitative study of early parental experience , 2011, International journal of pediatric endocrinology.
[59] R. Rey,et al. Normal male sexual differentiation and aetiology of disorders of sex development. , 2011, Best practice & research. Clinical endocrinology & metabolism.
[60] A. Sinclair,et al. Inhibition of SRY-calmodulin complex formation induces ectopic expression of ovarian cell markers in developing XY gonads. , 2011, Endocrinology.
[61] O. Birk,et al. The LIM homeobox gene Lhx9 is essential for mouse gonad formation , 2000, Nature.
[62] P. Prentice,et al. Impact of the consensus statement and the new DSD classification system. , 2010, Best practice & research. Clinical endocrinology & metabolism.
[63] D. Higgs,et al. Mutations in a putative global transcriptional regulator cause X-linked mental retardation with α-thalassemia (ATR-X syndrome) , 1995, Cell.
[64] Michiko Nakamura,et al. Mamld1 Knockdown Reduces Testosterone Production and Cyp17a1 Expression in Mouse Leydig Tumor Cells , 2011, PloS one.
[65] J. Ludes-Meyers,et al. WWOX hypomorphic mice display a higher incidence of B‐cell lymphomas and develop testicular atrophy , 2007, Genes, chromosomes & cancer.
[66] James N. Hughes,et al. Identification of SOX3 as an XX male sex reversal gene in mice and humans. , 2011, Journal of Clinical Investigation.
[67] P. Goodfellow,et al. Expression of Sry, the mouse sex determining gene. , 1995, Development.
[68] R. Lovell-Badge,et al. Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer , 2008, Nature.
[69] S. Wells,et al. Gadd45γ and Map3k4 Interactions Regulate Mouse Testis Determination via p38 MAPK-Mediated Control of Sry Expression , 2012, Developmental cell.
[70] L. Looijenga,et al. Gonadal tumours and DSD. , 2010, Best practice & research. Clinical endocrinology & metabolism.
[71] A. Sinclair,et al. Characterisation of Urogenital Ridge Gene Expression in the Human Embryonal Carcinoma Cell Line NT2/D1 , 2007, Sexual Development.
[72] L. Nazarko. A new perspective on an old problem. , 2001, Nursing times.
[73] C. Niehrs,et al. GADD45G functions in male sex determination by promoting p38 signaling and Sry expression. , 2012, Developmental cell.
[74] R. Giorda,et al. XX males SRY negative: a confirmed cause of infertility , 2011, Journal of Medical Genetics.
[75] J. Jameson,et al. Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. , 2002, The Journal of clinical endocrinology and metabolism.
[76] M. Mazzilli,et al. Syndromic true hermaphroditism due to an R‐spondin1 (RSPO1) homozygous mutation , 2008, Human mutation.
[77] T. Kidokoro,et al. Cbx2, a polycomb group gene, is required for Sry gene expression in mice. , 2012, Endocrinology.
[78] V. Vidal,et al. Sox9 induces testis development in XX transgenic mice , 2001, Nature Genetics.
[79] S. Bornstein,et al. Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[80] James Newsome,et al. Analysis and Recommendations , 2014 .
[81] J. Jameson,et al. Dax1 is required for testis determination , 2003, Nature Genetics.
[82] I. Hughes,et al. UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development , 2011, Clinical endocrinology.
[83] W. Dobyns,et al. Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans , 2002, Nature Genetics.
[84] M. Primig,et al. XY Sox9 embryonic loss-of-function mouse mutants show complete sex reversal and produce partially fertile XY oocytes. , 2011, Developmental biology.
[85] Peter Goodfellow,et al. "Male Development of Chromosomally Female Mice Transgenic for Sry gene" (1991), by Peter Koopman, et al. , 2014 .
[86] L. Looijenga,et al. Gonadal Development and Tumor Formation at the Crossroads of Male and Female Sex Determination , 2011, Sexual Development.
[87] E. Vilain,et al. We used to call them hermaphrodites , 2007, Genetics in Medicine.
[88] David I. Wilson,et al. SRY, SOX9, and DAX1 expression patterns during human sex determination and gonadal development , 2000, Mechanisms of Development.
[89] J. Beckmann,et al. The region on 9p associated with 46,XY sex reversal contains several transcripts expressed in the urogenital system and a novel doublesex-related domain. , 2000, Genomics.
[90] M. Taketo,et al. Loss of Fgfr2 leads to partial XY sex reversal. , 2008, Developmental biology.
[91] Sahar Mansour,et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene , 1994, Nature.
[92] J. Epstein,et al. Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[93] E. Schoenle,et al. Ovaries and female phenotype in a girl with 46,XY karyotype and mutations in the CBX2 gene. , 2009, American journal of human genetics.
[94] B. Capel,et al. Testis development requires the repression of Wnt4 by Fgf signaling. , 2012, Developmental biology.
[95] A. Biason-Lauber. Control of sex development. , 2010, Best practice & research. Clinical endocrinology & metabolism.
[96] A. Sinclair,et al. A multi-exon deletion within WWOX is associated with a 46,XY disorder of sex development , 2011, European Journal of Human Genetics.
[97] C. Woods,et al. A SOX9 duplication and familial 46,XX developmental testicular disorder. , 2011, New England Journal of Medicine.
[98] K. McElreavey,et al. Loss-of-function mutation in GATA4 causes anomalies of human testicular development , 2011, Proceedings of the National Academy of Sciences.
[99] A. Monaco,et al. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita , 1994, Nature.
[100] Y. Gondo,et al. ENU-based gene-driven mutagenesis in the mouse: a next-generation gene-targeting system. , 2010, Experimental animals.
[101] W. Shen,et al. Nuclear receptor steroidogenic factor 1 regulates the müllerian inhibiting substance gene: A link to the sex determination cascade , 1994, Cell.
[102] P. Hindmarsh,et al. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans , 1999, Nature Genetics.
[103] P N Goodfellow,et al. DNA binding activity of recombinant SRY from normal males and XY females. , 1992, Science.
[104] A. Sinclair,et al. Wnt signaling in ovarian development inhibits Sf1 activation of Sox9 via the Tesco enhancer. , 2012, Endocrinology.
[105] E. Schoenle,et al. A WNT4 mutation associated with Müllerian-duct regression and virilization in a 46,XX woman. , 2004, The New England journal of medicine.
[106] G. Tate,et al. A novel mutation of desert hedgehog in a patient with 46,XY partial gonadal dysgenesis accompanied by minifascicular neuropathy. , 2000, American journal of human genetics.
[107] P. de Santa Barbara,et al. Steroidogenic Factor-1 Contributes to the Cyclic-Adenosine Monophosphate Down-Regulation of Human SRY Gene Expression1 , 2001, Biology of reproduction.
[108] Anwar Hossain,et al. The Human Sex-determining Gene SRY Is a Direct Target of WT1 * , 2001, The Journal of Biological Chemistry.
[109] K. McElreavey,et al. Mutation Analysis of NR5A1 Encoding Steroidogenic Factor 1 in 77 Patients with 46, XY Disorders of Sex Development (DSD) Including Hypospadias , 2011, PloS one.
[110] A. Monaco,et al. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism , 1994, Nature.
[111] R. Lovell-Badge,et al. Somatic Sex Reprogramming of Adult Ovaries to Testes by FOXL2 Ablation , 2009, Cell.
[112] D. Housman,et al. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome , 1991, Cell.
[113] X. Chen,et al. Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans. , 2001, American journal of human genetics.
[114] R. Lovell-Badge,et al. Dax1 antagonizes Sry action in mammalian sex determination , 1998, Nature.
[115] T. Ogata,et al. Mastermind-like Domain-containing 1 (MAMLD1 or CXorf6) Transactivates the Hes3 Promoter, Augments Testosterone Production, and Contains the SF1 Target Sequence* , 2008, Journal of Biological Chemistry.
[116] E. Dellambra,et al. R-spondin1 is essential in sex determination, skin differentiation and malignancy , 2006, Nature Genetics.
[117] Soheila Sharghi Namini,et al. Schwann Cell–Derived Desert Hedgehog Controls the Development of Peripheral Nerve Sheaths , 1999, Neuron.
[118] K. McElreavey,et al. Mutations in NR5A1 associated with ovarian insufficiency. , 2009, The New England journal of medicine.
[119] M. Taketo,et al. Stabilization of beta-catenin in XY gonads causes male-to-female sex-reversal. , 2008, Human molecular genetics.
[120] M. Griswold,et al. DMRT1 prevents female reprogramming in the postnatal mammalian testis , 2011, Nature.
[121] A. Sinclair,et al. CITED2 mutations potentially cause idiopathic premature ovarian failure. , 2012, Translational research : the journal of laboratory and clinical medicine.
[122] E. Olson,et al. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. , 1997, Genes & development.
[123] Peter A. Lee,et al. Disorders of sex development , 2007, Current opinion in obstetrics & gynecology.
[124] D. Schlessinger,et al. Loss of Wnt4 and Foxl2 leads to female-to-male sex reversal extending to germ cells. , 2007, Human molecular genetics.
[125] D. Accili,et al. Testis determination requires insulin receptor family function in mice , 2003, Nature.
[126] Shoudan Liang,et al. Identification of SOX9 Interaction Sites in the Genome of Chondrocytes , 2010, PloS one.
[127] K Sigrist,et al. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. , 1997, Genes & development.
[128] M. Fellous,et al. A novel mutation in the putative DNA helicase XH2 is responsible for male-to-female sex reversal associated with an atypical form of the ATR-X syndrome. , 1996, American journal of human genetics.
[129] S. Aizawa,et al. Defects of urogenital development in mice lacking Emx2. , 1997, Development.
[130] R. Behringer,et al. Cell-specific knockout of steroidogenic factor 1 reveals its essential roles in gonadal function. , 2004, Molecular endocrinology.
[131] P. Hunsicker,et al. Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[132] Jonathan C. Cohen,et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5 , 2003, Nature.
[133] M. Wegner,et al. Functional analysis of Sox8 and Sox9 during sex determination in the mouse , 2004, Development.
[134] A. McMahon,et al. Female development in mammals is regulated by Wnt-4 signalling , 1999, Nature.
[135] Y. Fukushima,et al. Sex-determining gene(s) on distal 9p: clinical and molecular studies in six cases. , 2000, The Journal of clinical endocrinology and metabolism.
[136] A. Sinclair,et al. Genetic evidence equating SRY and the testis-determining factor , 1990, Nature.
[137] Y. Katoh-Fukui,et al. Male-to-female sex reversal in M33 mutant mice , 1998, Nature.
[138] P. Chatelain,et al. Surgical options in disorders of sex development (dsd) with ambiguous genitalia. , 2010, Best practice & research. Clinical endocrinology & metabolism.
[139] David C Page,et al. Direct reprogramming of fibroblasts into embryonic Sertoli-like cells by defined factors. , 2012, Cell stem cell.
[140] Peter Koopman,et al. Expression profiling of purified mouse gonadal somatic cells during the critical time window of sex determination reveals novel candidate genes for human sexual dysgenesis syndromes. , 2006, Human molecular genetics.
[141] H. Ostrer,et al. Mutations in MAP3K1 cause 46,XY disorders of sex development and implicate a common signal transduction pathway in human testis determination. , 2010, American journal of human genetics.
[142] Y. Ning,et al. Autosomal XX sex reversal caused by duplication of SOX9. , 1999, American journal of medical genetics.
[143] D. Page,et al. Follistatin operates downstream of Wnt4 in mammalian ovary organogenesis , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.
[144] Frances P Lawrenz,et al. Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations , 2008, The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.
[145] G. Stein,et al. Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor leads to impaired steroidogenesis. , 2009, Endocrinology.
[146] Robin Lovell-Badge,et al. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif , 1990, Nature.
[147] P. Wieacker,et al. Mutations of the SRY-Responsive Enhancer of SOX9 Are Uncommon in XY Gonadal Dysgenesis , 2010, Sexual Development.
[148] W. Grody,et al. Targeted massively parallel sequencing provides comprehensive genetic diagnosis for patients with disorders of sex development , 2013, Clinical genetics.
[149] R. Kist,et al. Homozygous Inactivation of Sox9 Causes Complete XY Sex Reversal in Mice1 , 2006, Biology of reproduction.
[150] D. Wilhelm,et al. Sertoli cell differentiation is induced both cell-autonomously and through prostaglandin signaling during mammalian sex determination. , 2005, Developmental biology.
[151] P. Wieacker,et al. Partial deletion of DMRT1 causes 46,XY ovotesticular disorder of sexual development. , 2012, European journal of endocrinology.
[152] A. Sinclair,et al. Mammalian sex determination—insights from humans and mice , 2012, Chromosome Research.
[153] A. Schedl,et al. Two Splice Variants of the Wilms' Tumor 1 Gene Have Distinct Functions during Sex Determination and Nephron Formation , 2001, Cell.